Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors Post author: Post published:December 4, 2023 Post category:uncategorized Refeyn, a leader in mass photometry technology, announces the launch of its macro mass photometry platform, KaritroMP. You Might Also Like Anne Bang joins research to understand the genetic underpinnings of psychiatric conditions October 13, 2024 Enfortumab vedotin and pembrolizumab show major benefits for urothelial carcinoma patients April 6, 2025 Cancer researchers urged to embrace AI for groundbreaking insights and efficiency May 19, 2024
Anne Bang joins research to understand the genetic underpinnings of psychiatric conditions October 13, 2024
Enfortumab vedotin and pembrolizumab show major benefits for urothelial carcinoma patients April 6, 2025